A Facile Access to the 1,5-Dihydro- and 1,3,4,5-Tetrahydro-benzo[b]azepin-2-one Ring Systems via a New Ring Enlargement

Abstract

Synthesis of a 1,5-dihydro-benzo[b]azepin-2-one is reported. The key reaction is a silver nitrate-induced rearrangement of N-benzyl quinolinium bromide. Its reduction leads to the 1,3,4,5-tetrahydro-benzo[b] azepin-2-one ring system found in several pharmacological important compounds.

quinolinium salt - silver nitrate - 1,5-dihydro-benzo[b]azepin-2-one - 1,3,4,5-tetrahydro-benzo[b] azepin-2-one - ring enlargement

References

1 Schultz C. Link A. Leost M. Zaharevitz DW. Gussio R. Sausville EA. Meijer L. Kunick C. J. Med. Chem.  1999,  42:  2909 

2a Blaser HU. Boyer S. Pittelkow U. Tetrahedron: Asymmetry  1991,  2:  721 

2b Boyer SK. Pfund RA. Portmann RE. Sedelmeier GH. Wetter HF. Helv. Chim. Acta  1988,  71:  337 

2c Watthey JWH. Stanton JL. Desai M. Babiarz JE. Finn BM. J. Med.Chem.  1985,  28:  1511 

3 Hansen TH. Thøgersen H. Hansen BS. Bioorg. Med. Chem. Lett.  1997,  7:  2951 

4a Das J. Floyd DM. Kimball DS. Duff KJ. Truc ChiVu. Lago MW. Moquin RV. Lee VG. Gougoutas JZ. Malley MF. Moreland S. Brittain RJ. Hedberg SA. Cucinotta GG. J. Med. Chem.  1992,  35:  773 

4b Das J. Floyd DM. Kimball DS. Duff KJ. Lago MW. Krapcho J. White R. Ridgewell R. Obermeier MT. Moreland S. McMullen D. Normandin D. Hedberg SA. Schaeffer T. J. Med. Chem.  1992,  35:  2610 

5a Rickards RW. Smith RM. Tetrahedron Lett.  1966,  2361 

5b Kozikowski AP. Ma D. Brewer J. Sun S. Costa E. Romeo E. Guidotti A. J. Med. Chem.  1993,  36:  2908 

6 Duchardt KH. Kröhnke F. Chem. Ber.  1977,  110:  2669 

7 Maeda M. Chem. Pharm. Bull.  1990,  38:  2577 

8 Grignon-Dubois M. Diaba F. Grellier-Marly M.-C. Synthesis  1994,  800 

9

Spectral Data for Compound 5:
IR (KBr): 1659, 1615, 1595 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 3.40 (s, 3 H, OCH ₃), 4.82 (br s, 1 H, CHOCH₃), 5.08 and 5.40 (AB system, J = 15.2 Hz, 2 H, NCH ₂), 5.84 (d, J = 11.2 Hz, 1 H, COCH=CH), 6.51 (dd, J = 11.2 and 4.0 Hz, 1 H, COCH=CH), 7.05-7.45 (m, 9 H, Ar). ¹³C NMR (50 MHz, CDCl₃): δ = 52.4, 57.7, 77.2, 121.3, 122.6, 123.1, 125.7, 127.3, 127.4, 127.5 (2 C), 128.5 (2 C), 137.7, 138.3 (2 quaternary carbons), 146.1, 166.5. MS: m/z (relative intensity) = 279(8) [M⁺], 264(19), 246(30), 91(100), 65(18). HRMS (SIMS) calcd for C₁₈H₁₇NO₂ + H: 280.1338; found: 280.1342.

10a MacPhillamy HB. Dziemian RL. Lucas RA. Kuehne ME. J. Am. Chem. Soc.  1958,  80:  2172 

10b Kunick C. Arch Pharm.  1991,  324:  579 

11a Hauser FM. Prasanna S. Synthesis  1980,  621 

11b Baskaran S. Das J. Chandrasekaran S. J. Org. Chem.  1989,  54:  5182 

12

For a close example of Beckmann rearrangement, see ref. [2b]

13

Spectral Data for Compounds 9 and 10:
9: IR (KBr): 1667 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.70-1.90 (m, 1 H, CH ₂CHOCH₃), 2.15-2.35 (m, 2 H, CH ₂CO), 2.45-2.65 (m, 1 H, CH ₂CHOCH₃), 3.06 (s, 3 H, OCH ₃), 4.01 (dd, J = 10.4 and 6.8 Hz, 1 H, CHOCH₃), 4.63 and 5.37 (AB system, J = 14.4 Hz, 2 H, NCH ₂), 7.10-7.35 (m, 9 H, Ar). ¹³C NMR (50 MHz, CDCl₃): δ = 31.8, 35.4, 51.3, 57.6, 77.5, 123.3, 124.6, 126.7, 127.5, 128.1, 128.5 (4 C; the ortho and meta carbons of the phenyl ring are identical), 135.9, 137.6, 140.5, 172.6. MS: m/z (relative intensity) = 281(24) [M⁺], 194(58), 130(100), 91(90), 65(22). HRMS (SIMS) calcd for C₁₈H₁₉NO₂ + H: 282.1494; found: 282.1491.
10: IR (KBr): 1674 cm^-1; ¹H NMR (200 MHz, CDCl₃): δ = 2.00-2.20 (m, 1 H of the CH₂CH₂ motif), 2.30-2.60 (m, 3 H of the CH₂CH₂ motif), 3.32 (s, 3 H, OCH ₃), 3.70-3.85 (m, 1 H, CHOCH₃), 4.90 and 5.24 (AB system, J = 14.8 Hz, 2 H, NCH ₂), 7.05-7.30 (m, 9 H, Ar). ¹³C NMR (50 MHz, CDCl₃): δ = 27.8, 36.2, 51.8, 57.9, 78.1, 123.1, 126.7, 127.5, 127.8, 128.3 (2 C), 128.5 (2 C), 129.1, 136.1, 137.6, 140.7, 171.6. MS: m/z (relative intensity) = 281(96) [M⁺], 132(79), 118(76), 91(100), 65(20). HRMS (SIMS) calcd for C₁₈H₁₉NO₂ + H: 282.1494; found: 282.1495.

14 For a recent example of a proline derivative enlargement, see: Cossy J. Dumas C. Gomez Pardo D. Synlett  1997,  905